Want to see SE:ORGC full AI Analyst Report?
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.20 - kr1.90
Previous CloseN/A
Volume11.05K
Average Volume (3M)262.35K
Market Cap
kr51.12M
Enterprise Valuekr130.45M
Total Cash (Recent Filing)kr480.00K
Total Debt (Recent Filing)kr78.56M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding183,219,120
10 Day Avg. Volume298,709
30 Day Avg. Volume262,347
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
Bulls Say, Bears Say
Bulls Say
Moderating Cash BurnThe reduction in cash outflow is an important early sign that financial pressure may be easing, even though cash generation remains negative. If maintained, better cash discipline could extend liquidity, reduce funding needs, and support progress toward self-funding operations.
Improved Losses Versus 2022Improvement from the exceptionally weak 2022 result shows that the company has demonstrated some capacity to reduce losses over time. This does not offset current weakness, but it provides evidence that operational performance can improve if cost control and commercial execution strengthen.
Proprietary Bio-Based ChemistryA proprietary bio-based chemistry platform gives OrganoClick a defined product foundation across several treatment applications. Its focus on replacing fossil-based and hazardous chemicals can support longer-term differentiation as customers seek more sustainable inputs, provided adoption and scale continue.
Bears Say
Declining RevenueDeclining revenue indicates that demand, customer adoption, or sales execution is not currently producing durable top-line expansion. Continued contraction would reduce operating leverage, limit investment capacity, and make it harder for the company to absorb fixed costs or improve profitability.
Deep Negative MarginsDeeply negative operating and net margins show that the current business model is not yet converting sales into sustainable earnings. Margin compression versus earlier periods adds concern that pricing, product mix, or costs are weakening, making a durable return to profitability more difficult.
High Leverage And Negative Cash FlowDebt materially exceeding equity leaves limited balance-sheet flexibility, while negative operating and free cash flow show that the business is not self-funding. Together, these conditions increase refinancing and dilution risk and constrain the company’s ability to invest through a prolonged recovery.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.20 and its highest was kr1.90 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr51.12M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Nov 05, 2026 which is in 13 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Aug 12, 2026. The company reported -kr0.037 earnings per share for the quarter.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.037 in its last earnings report. Following the earnings report the stock price went down -13.474%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Hexpol AB
―
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Photocat A/S
―